We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Physiomics Plc | LSE:PYC | London | Ordinary Share | GB00BDR6W943 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.55 | 1.40 | 1.70 | 0.00 | 07:40:09 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 597k | -477k | -0.0035 | -4.43 | 2.1M |
TIDMPYC
RNS Number : 0902Z
Physiomics PLC
12 December 2017
12(th) December 2017
Physiomics plc
("Physiomics") or ("the Company")
Director Dealing
The Company announces that it received notice today that the following Directors sold the following number of ordinary shares in the Company at the following prices per share:
Director Number of shares Sale price per sold share ------------------- ----------------- --------------- Dr J Millen, CEO 240,000 8.3p ------------------- ----------------- --------------- Dr C Chassagnole, COO 600,000 8.3p ------------------- ----------------- ---------------
Following the sales of shares, the total holdings of each Director of the Company will be as follows:
Dr Paul Harper 525,707 Dr Jim Millen 444,641 Dr Christophe Chassagnole 417,008
The total number of shares in issue remains 58,785,394 Ordinary Shares with voting rights attached (one vote per Share). There are no Shares held in treasury. This total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in, Physiomics under the Disclosure and Transparency Rules.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1 Details of the person discharging managerial responsibilities/person closely associated --- ----------------------------------------------------------------------------------------------- a) Name James Millen --- -------------------------------------------------------------------- ------------------------- 2 Reason for the notification --- ----------------------------------------------------------------------------------------------- a) Position/status Director, CEO --- -------------------------------------------------------------------- ------------------------- b) Initial notification/ Amendment Initial notification --- -------------------------------------------------------------------- ------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ----------------------------------------------------------------------------------------------- a) Name Physiomics plc --- -------------------------------------------------------------------- ------------------------- b) LEI 213800A71DSZ6ABMTQ91 --- -------------------------------------------------------------------- ------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ----------------------------------------------------------------------------------------------- a) Description of the financial instrument, type of instrument Ordinary share Identification code GB00BDR6W943 --- -------------------------------------------------------------------- ------------------------- b) Nature of the transaction Disposal of shares --- -------------------------------------------------------------------- ------------------------- c) Price(s) and volume(s) Price(s) Volume(s) --------- ---------- 8.3p 240,000 --------- ---------- --- -------------------------------------------------------------------- ------------------------- d) Aggregated information * Aggregated volume 240,000 At 8.3p per share * Price --- -------------------------------------------------------------------- ------------------------- e) Date of the transaction 12-12-2017 --- -------------------------------------------------------------------- ------------------------- f) Place of the transaction XLON, AIM --- -------------------------------------------------------------------- -------------------------
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1 Details of the person discharging managerial responsibilities/person closely associated --- ----------------------------------------------------------------------------------------------- a) Name Christophe Chassagnole --- -------------------------------------------------------------------- ------------------------- 2 Reason for the notification --- ----------------------------------------------------------------------------------------------- a) Position/status Director, COO --- -------------------------------------------------------------------- ------------------------- b) Initial notification/ Amendment Initial notification --- -------------------------------------------------------------------- ------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ----------------------------------------------------------------------------------------------- a) Name Physiomics plc --- -------------------------------------------------------------------- ------------------------- b) LEI 213800A71DSZ6ABMTQ91 --- -------------------------------------------------------------------- ------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ----------------------------------------------------------------------------------------------- a) Description of the financial instrument, type of instrument Ordinary share Identification code GB00BDR6W943 --- -------------------------------------------------------------------- ------------------------- b) Nature of the transaction Disposal of shares --- -------------------------------------------------------------------- ------------------------- c) Price(s) and volume(s) Price(s) Volume(s) --------- ---------- 8.3p 600,000 --------- ---------- --- -------------------------------------------------------------------- ------------------------- d) Aggregated information * Aggregated volume 600,000 At 8.3p * Price --- -------------------------------------------------------------------- ------------------------- e) Date of the transaction 12-12-2017 --- -------------------------------------------------------------------- ------------------------- f) Place of the transaction XLON, AIM --- -------------------------------------------------------------------- -------------------------
Enquiries:
Physiomics plc
Dr Jim Millen, CEO
+44 (0)1865 784 980
WH Ireland Limited (nomad)
Katy Mitchell, James Sinclair-Ford
+44 (0) 161 832 2174
Hybridan LLP (broker)
Claire Louise Noyce
+44 (0) 203 764 2341
The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHTTBMTMBBBBIR
(END) Dow Jones Newswires
December 12, 2017 05:17 ET (10:17 GMT)
1 Year Physiomics Chart |
1 Month Physiomics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions